Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for prevention of shivering after spinal anesthesia in cesarean section
IRCT20121209011700N10Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ondansetron in postanesthetic shivering (PAS) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Shivering severity, Need for pethidine and 3 more. Started Aug 2019; status: completed.
02
Drugs
ondansetron
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20121209011700N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121209011700N10.